| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 5IB2J79MCX |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | IL36 receptor antagonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 4 | D011565 | ClinicalTrials |
| Hidradenitis Suppurativa | 2 | D017497 | ClinicalTrials |
| Pyoderma | 2 | D011711 | ClinicalTrials |
| Netherton Syndrome | 2 | D056770 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297911 |
| FDA SRS | 5IB2J79MCX |
CONTENTS